Skip to main content
SpringerLink
Log in

RE: Effects of adjuvant chemotherapy on recurrence, survival and quality of life in stage II colon cancer patients: a 24-month follow-up

  • Letter to the editor
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lewis C, Xun P, He K (2016) Effects of adjuvant chemotherapy on recurrence, survival, and quality of life in stage II colon cancer patients: a 24-month follow-up. Support Care Cancer: Off J Multinatl Assoc Support Care Cancer 24(4):1463–1471. doi:10.1007/s00520-015-2931-2

    Article  Google Scholar 

  2. Benson AB 3rd, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, Krzyzanowska MK, Maroun J, McAllister P, Van Cutsem E, Brouwers M, Charette M, Haller DG (2004) American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 22(16):3408–3419. doi:10.1200/JCO.2004.05.063

    Article  PubMed  Google Scholar 

  3. Verhoeff SR, van Erning FN, Lemmens VE, de Wilt JH, Pruijt JF (2016) Adjuvant chemotherapy is not associated with improved survival for all high risk factors in stage II colon cancer. Int J Cancer. doi:10.1002/ijc.30053

    PubMed  Google Scholar 

  4. Morris M, Platell C, de Boer B, McCaul K, Iacopetta B (2006) Population-based study of prognostic factors in stage II colonic cancer. Br J Surg 93(7):866–871. doi:10.1002/bjs.5345

    Article  CAS  PubMed  Google Scholar 

  5. Lindskog EB, Gunnarsdottir KA, Derwinger K, Wettergren Y, Glimelius B, Kodeda K (2014) A population-based cohort study on adherence to practice guidelines for adjuvant chemotherapy in colorectal cancer. BMC Cancer 14:948. doi:10.1186/1471-2407-14-948

    Article  PubMed  PubMed Central  Google Scholar 

  6. Andersen PK, Geskus RB, de Witte T, Putter H (2012) Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol 41(3):861–870. doi:10.1093/ije/dyr213

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Research, Netherlands Comprehensive Cancer Organisation (IKNL), Zernikestraat 29, 5612 HZ, Eindhoven, The Netherlands

    F. N. van Erning, P. A. J. Vissers & V. E. P. P. Lemmens

  2. Department of Public Health, Erasmus University Medical Centre, Rotterdam, The Netherlands

    F. N. van Erning & V. E. P. P. Lemmens

  3. Department of Medical Oncology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands

    C. J. A. Punt

Authors
  1. F. N. van Erning
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. A. J. Vissers
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. J. A. Punt
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. V. E. P. P. Lemmens
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F. N. van Erning.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

van Erning, F.N., Vissers, P.A.J., Punt, C.J.A. et al. RE: Effects of adjuvant chemotherapy on recurrence, survival and quality of life in stage II colon cancer patients: a 24-month follow-up. Support Care Cancer 24, 4079–4080 (2016). https://doi.org/10.1007/s00520-016-3267-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-016-3267-2

Keywords

Search

Navigation